Premium
‘Treat to target’ for rheumatoid arthritis in 2014 – time tested triple therapy or logical Biologics?
Author(s) -
Mok Mo Yin,
Danda Debashish
Publication year - 2014
Publication title -
international journal of rheumatic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.795
H-Index - 41
eISSN - 1756-185X
pISSN - 1756-1841
DOI - 10.1111/1756-185x.12313
Subject(s) - medicine , abatacept , tocilizumab , tofacitinib , rheumatoid arthritis , rituximab , anakinra , disease , immunology , antibody
Open Access Journallink_to_OA_fulltex